You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
BioPorto - Presentation of strategic plans
By HC Andersen Capital
You can already now sign up for the event and send in your questions. You don’t have to participate live to send in questions for the event.
Meet and ask questions to interim CEO Peter Mørch Eriksen from BioPorto on 22 February at 2.00 PM.
BioPorto - an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI) - will publish its strategic plans.
Disclaimer: HC Andersen Capital receives payment from Bioporto for a DigitalIR/Corporate Visibility and IR advisory agreement./Claus Thestrup 20 February 08.57 AM.